Cannabix (BLO.C) finally has a marijuana breath test, 10 years after they claimed it
There are few phrases in the junior markets more dangerous than “in the coming weeks.” “In the coming months” is another good one. “Soon…
Read story
EQUITY.GURU / HEALTH SCIENCE
Health Science & Biotech
Explore Canadian biotech stocks, emerging healthcare companies and innovations in medical technology, pharmaceuticals, diagnostics and life sciences. Independent reporting and investment analysis from Equity.Guru.
Looking back: Vitalhub (VHI.T) doubled on our articles, then went 10x in the years since
Back in 2018, I wrote often about a medtech company called Vitalhub (VHI.T). Essentially, they were at the starting point of what we now…
Read story
BioNxt (BNXT.C) rips as European Patent Office backs Cladribine thin-film
BioNxt Solutions (CSE: BNXT) received a share price boost today after announcing the European Patent Office and its Eurasian counterpart have waved through core…
Read story
NetraMark Holdings (AIAI.C): Failed FDA trials cost billions, NetraAI may prevent them
I see a lot of company pitches in my job. I also see a lot of AI pitches. I don’t see a lot of…
Read story
Hemostenix (HEMO.V): Bringing back that lovin’ feeling.. and up 400% in a month
Hemostenix (HEM.V) has been lifting off of late, and as we’ve seen some real upward movement in the pharmaceuticals/biotech space in Canada of late…
Read story
Onco Innovations (ONCO.C): What if we could stop cancer coming back?
This past month I’ve had three conversations with friends that included the following sentences. “It’s been two years but something doesn’t feel right, I’m…
Read story
Voyageur Pharmaceuticals (VM) took a mine and turned it into a pharma company
Quite often, when I talk to mining explorers, I’m left to wonder why their focus is so often on digging things out of the…
Read story
Can your phone confirm you have strep throat? Light AI (ALGO.E) says yes
Light AI’s claim: That it can revolutionize health diagnostics with your smartphone Imagine a world where diagnosing illnesses is as easy as snapping a…
Read story
Bionxt Solutions (BNXT.C): Seeking to confirm national-level cancer drug patent
As the world increasingly faces the complexities of autoimmune and neurodegenerative diseases, new medical advancements are crucial to better serve patients’ needs. Enter Bionxt…
Read story
Pubcos extending warrants as summer drags on, hoping for cash injection in months ahead
Canadian-listed, German-based bioscience accelerator BioNxt (BNXT.C) has announced it plans to give warrant holders an additional year to exercise 2022-purchased $0.50 warrants of the…
Read story
BioNxt Solutions (BNXT.C) to spark marketing as ODF human studies begin
Biotech companies are notoriously difficult to find investor love for in Canada, at least historically, so it’s no surprise that BioNxt Solutions (BNXT.C) is…
Read story
Revive Therapeutics (RVV.CN) provides update on FDA Type C Meeting
Revive Therapeutics (RVV.V) is a specialty life sciences company focused on the research and development of therapeutics for…
Read story